News & Events
Nanopharm News & Events
Nanopharm is continually expanding its specialized nasal and inhaled drug delivery development capabilities and participates in numerous events within the OINDP pharmaceutical community. Learn more about the latest news and events at Nanopharm.
18 July 2025
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation.
Filter Resources By
02 Jan 2020
DPI, Drug Development, Dry powder inhaler, Fluticasone Propionate, Inhalation
12 Jul 2019
Annealing, DPI, Drug Development, Dry powder inhaler, Micronized, Molecular SFE, Nanopharm
01 Feb 2018
bioequivalence, Drug Development, Formulation, Generic, Nasal, OINDP
01 Feb 2016
bioequivalence, drug delivery, In Vitro, Nanopharm, Nasal, Particle Size
01 Sep 2015
Computational Fluid Dynamics, DPIs, Dry Powder Inhalers, In Vitro, Nanopharm, particle size distribution
01 Jun 2015
APSD, DPI, Dry powder inhaler, Fluticasone Propionate, Nanopharm, Structural Dynamics
